Epcoritamab monotherapy or epcoritamab with lenalidomide as first-line therapy for patients with diffuse large B-cell lymphoma (EPCORE DLBCL-3): primary analysis of an open-label, multicentre, randomised, phase 2 trial.
来源：PubMed发布日期：2026-06-12作者：Vitolo U, Burgues JMB, Duell J, Kwiatek M, Belada D0 次点击